BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33511359)

  • 1. Ultrarapid
    Arcila ME; Yang SR; Momeni A; Mata DA; Salazar P; Chan R; Elezovic D; Benayed R; Zehir A; Buonocore DJ; Rekhtman N; Lin O; Ladanyi M; Nafa K
    JTO Clin Res Rep; 2020 Sep; 1(3):. PubMed ID: 33511359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid EGFR Mutation Detection Using the Idylla Platform: Single-Institution Experience of 1200 Cases Analyzed by an In-House Developed Pipeline and Comparison with Concurrent Next-Generation Sequencing Results.
    Momeni-Boroujeni A; Salazar P; Zheng T; Mensah N; Rijo I; Dogan S; Yao J; Moung C; Vanderbilt C; Benhamida J; Chang J; Travis W; Rekhtman N; Ladanyi M; Nafa K; Arcila ME
    J Mol Diagn; 2021 Mar; 23(3):310-322. PubMed ID: 33346146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and reliable testing for clinically actionable EGFR mutations in non-small cell lung cancer using the Idylla
    Michaelidou K; Karniadakis I; Pantelaion V; Koutoulaki C; Boukla E; Folinas K; Dimaras P; Papadaki MA; Koutsopoulos AV; Mavroudis D; Vourlakou C; Mavridis K; Agelaki S
    Expert Rev Mol Diagn; 2024; 24(1-2):89-98. PubMed ID: 38193169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idylla assay and next generation sequencing: an integrated EGFR mutational testing algorithm.
    De Luca C; Rappa AG; Gragnano G; Malapelle U; Troncone G; Barberis M
    J Clin Pathol; 2018 Aug; 71(8):745-750. PubMed ID: 29798838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idylla
    Khalifa E; Chapusot C; Tournier B; Sentis J; Marion E; Remond A; Aubry M; Pioche C; Bergeron A; Primois C; Blanchard L; Millière A; Boucheix M; Léger Y; Bairrao M; Brouste V; Martin L; Soubeyran I
    J Clin Pathol; 2023 Oct; 76(10):698-704. PubMed ID: 35820776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complementing Tissue Testing With Plasma Mutation Profiling Improves Therapeutic Decision-Making for Patients With Lung Cancer.
    Choudhury Y; Tan MH; Shi JL; Tee A; Ngeow KC; Poh J; Goh RR; Mong J
    Front Med (Lausanne); 2022; 9():758464. PubMed ID: 35223889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the Idylla system to detect the EGFR
    Bocciarelli C; Cohen J; Pelletier R; Tran Van Nhieu J; Derman J; Favre L; Bourgogne A; Monnet I; Chouaid C; Pujals A
    Pathol Res Pract; 2020 Jan; 216(1):152773. PubMed ID: 31836323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced sensitivity for
    Lee E; Jones V; Topkas E; Harraway J
    J Clin Pathol; 2021 Jan; 74(1):43-47. PubMed ID: 32467321
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    De Luca C; Gragnano G; Pisapia P; Vigliar E; Malapelle U; Bellevicine C; Troncone G
    J Clin Pathol; 2017 Apr; 70(4):295-300. PubMed ID: 27543600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of the Idylla
    Petiteau C; Robinet-Zimmermann G; Riot A; Dorbeau M; Richard N; Blanc-Fournier C; Bibeau F; Deshayes S; Bergot E; Gervais R; Levallet G
    Curr Oncol; 2021 Nov; 28(6):4432-4445. PubMed ID: 34898548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Idylla™ EGFR Mutation Test on formalin-fixed, paraffin-embedded tissue of human lung cancer.
    Xu Y; Zhang L; Jia L; Ren M; Xue T; Bai Q; Yao Q; Wei R; Zhou X; Zhu X
    J Thorac Dis; 2024 Jan; 16(1):40-50. PubMed ID: 38410581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter Evaluation of the Fully Automated PCR-Based Idylla EGFR Mutation Assay on Formalin-Fixed, Paraffin-Embedded Tissue of Human Lung Cancer.
    Evrard SM; Taranchon-Clermont E; Rouquette I; Murray S; Dintner S; Nam-Apostolopoulos YC; Bellosillo B; Varela-Rodriguez M; Nadal E; Wiedorn KH; Melchior L; Andrew E; Jones M; Ridgway J; Frykman C; Lind L; Rot M; Kern I; Speel EJM; Roemen GMJM; Trincheri N; Freiberger SN; Rechsteiner M
    J Mol Diagn; 2019 Nov; 21(6):1010-1024. PubMed ID: 31445213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a fast and fully automated platform to diagnose
    Lambros L; Caumont C; Guibourg B; Barel F; Quintin-Roué I; Marcorelles P; Merlio JP; Uguen A
    J Clin Pathol; 2017 Jun; 70(6):544-549. PubMed ID: 28153953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paired Comparison of Routine Molecular Screening of Patient Samples with Advanced Non-Small Cell Lung Cancer in Circulating Cell-Free DNA Using Three Targeted Assays.
    Barthelemy D; Lescuyer G; Geiguer F; Grolleau E; Gauthier A; Balandier J; Raffin M; Bardel C; Bouyssounouse B; Rodriguez-Lafrasse C; Couraud S; Wozny AS; Payen L
    Cancers (Basel); 2023 Mar; 15(5):. PubMed ID: 36900363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the SuperARMS and ARMS for detecting EGFR mutations in liquid-based cytology specimens from NSCLC patients.
    Wu W; Cao Z; Zhang W; Zhang L; Hou L; Wu C
    Diagn Pathol; 2020 Jan; 15(1):9. PubMed ID: 32005253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of Select Gene Mutation Detection in Tumors by the Idylla Rapid Multiplex PCR Platform in Comparison to Next-Generation Sequencing.
    Nkosi D; Casler VL; Syposs CR; Oltvai ZN
    Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of Idylla KRAS assay on extracted DNA and de-stained cytology smears: Can we rescue small sample?
    Wei Q; Eltoum IA; Mackinnon AC; Harada S
    Ann Diagn Pathol; 2022 Oct; 60():152023. PubMed ID: 35961282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid Somatic Mutation Testing in Colorectal Cancer by Use of a Fully Automated System and Single-Use Cartridge: A Comparison with Next-Generation Sequencing.
    Al-Turkmani MR; Godwin KN; Peterson JD; Tsongalis GJ
    J Appl Lab Med; 2018 Sep; 3(2):178-184. PubMed ID: 33636938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of KRAS, NRAS and BRAF hotspot mutations detection for patients with metastatic colorectal cancer using direct DNA pipetting in a fully-automated platform and Next-Generation Sequencing for laboratory workflow optimisation.
    Gilson P; Franczak C; Dubouis L; Husson M; Rouyer M; Demange J; Perceau M; Leroux A; Merlin JL; Harlé A
    PLoS One; 2019; 14(7):e0219204. PubMed ID: 31265477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.